
Val75 of HIV-1 reverse transcriptase (RT) plays a role in positioning the template nucleotide +1, during the formation of the ternary complex. Mutations such as V75M and V75A emerge in patients infected with HIV-1 group M-subtype B and group O variants, after failing treatment with stavudine (d4T) and other nucleoside RT inhibitors. V75I is an accessory mutation of the Q151M multi-drug resistance complex of HIV-1 RT, and is rarely associated with thymidine analogue resistance mutations (TAMs). In vitro, it confers resistance to acyclovir. TAMs confer resistance to zidovudine (AZT) and d4T by increasing the rate of ATPmediated excision of the terminal nucleotide monophosphate (primer unblocking). In a wild-type HIV-1 group O RT sequence context, V75A and V75M conferred increased excision activity on d4T-terminated primers, in the presence of pyrophosphate (PPi). In contrast, V75I decreased the PPi-mediated unblocking efficiency on AZT and d4T-terminated primers, in different sequence contexts (i.e. wild-type group M-subtype B or group O RTs). Interestingly, in the sequence context of an excision-proficient RT (i.e., M41L/A62V/T69SSS/K70R/T215Y), the introduction of V75I led to a significant decrease of its ATP-dependent excision activity on AZT-, d4T-, and acyclovirterminated primers. The excision rate of d4T-monophosphate in the presence of ATP 3.2 mM was about 10 times higher for M41L/A62V/T69SSS/K70R/T215Y than for the mutant M41L/A62V/T69SSS/K70R/- V75I/T215Y RT. The antagonistic effect of V75I with TAMs was further demonstrated in phenotypic assays. Recombinant HIV-1 containing the M41L/A62V/T69SSS/- K70R/V75I/T215Y RT showed 18.3- and 1.5-fold increased susceptibility to AZT and d4T, respectively, in comparison with virus containing the M41L/A62V/T69SSS/- K70R/T215Y RT.
This work was supported by Spanish Ministry of Science and Innovation Grant BIO2007/60319, Fundacio´n para la Investigacio´n y Prevencio´n del SIDA en Espan˜ a (FIPSE) Grant 36771/08, the Fondo de Investigacio´n Sanitaria (through “Red Tema´tica de Investigacio´n Cooperativa en SIDA” Grant RD06/0006), and an institutional grant from the Fundacio´n Ramo´n Areces. This work was also supported by Spanish Ministry of Science and Innovation Grants BFU2006/01066 and PI07/0098 (to M. A. M.)
Peer reviewed
Anti-HIV Agents, DNA Mutational Analysis, Acyclovir, Valine, HIV-1 reverse transcriptase (RT), Drug Resistance, Multiple, HIV Reverse Transcriptase, Kinetics, Stavudine, Adenosine Triphosphate, Drug Resistance, Viral, HIV-1, Humans, Zidovudine, thymidine analogue resistance mutations (TAMs), DNA Primers, Thymidine
Anti-HIV Agents, DNA Mutational Analysis, Acyclovir, Valine, HIV-1 reverse transcriptase (RT), Drug Resistance, Multiple, HIV Reverse Transcriptase, Kinetics, Stavudine, Adenosine Triphosphate, Drug Resistance, Viral, HIV-1, Humans, Zidovudine, thymidine analogue resistance mutations (TAMs), DNA Primers, Thymidine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 13 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
